Antiplatelet Strategy for Peripheral Arterial Interventions for Revascularization of Lower Extremities
Status:
Completed
Trial end date:
2020-01-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate whether clopidogrel 75 mg daily on a background of
aspirin 75-100 mg/d for clinically indicated duration or for an additional 12 months will
lead to an increased rate of primary patency, limb salvage, non-fatal myocardial infarction
(MI), ischemic stroke, and survival, in patients receiving endovascular treatment of PAD at
end of study treatment.